These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 351757)

  • 1. [Acute effects of propranolol on the abnormal diastolic hemodynamics of the left ventricle in hypertrophic cardiomyopathy (author's transl)].
    Koga Y; Akiyoski T; Nagae K; Mizobuchi H; Toshima H
    Kokyu To Junkan; 1978 May; 26(5):473-6. PubMed ID: 351757
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical and hemodynamic effects of verapamil in hypertrophic obstructive cardiomyopathy].
    Lösse B; Kuhn H; Loogen F
    Z Kardiol; 1982 Dec; 71(12):813-9. PubMed ID: 6891873
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hemodynamic effects of propranolol on obstructive myocardiopathy].
    Ourbak P; Bourdarias JP; Cachin JC; Rocha P; Scebat L; Lenègre J
    Arch Mal Coeur Vaiss; 1971 Mar; 64(3):352-71. PubMed ID: 4397007
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of nifedipine and propranolol combined therapy in patients with hypertrophic cardiomyopathy.
    Hopf R; Kaltenbach M
    Z Kardiol; 1987; 76 Suppl 3():105-12. PubMed ID: 3433863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Beta-adrenergic blockers and calcium antagonists in hypertrophic cardiomyopathy].
    Korovina EP
    Klin Med (Mosk); 1998; 76(12):30-5. PubMed ID: 10067289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Echocardiographic and electrocardiographic evaluation of the effects of propranolol and verapamil in obstructive hypertrophic cardiomyopathy].
    Crittin J; Mayor C; Bloch A
    Ann Cardiol Angeiol (Paris); 1984 Apr; 33(3):185-9. PubMed ID: 6375537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of long-term treatment with verapamil on the clinical picture and exertion tolerance in patients with hypertrophic cardiomyopathy].
    Nowalany-Kozielska E; Wodniecki J; Tendera M; Poloński L
    Kardiol Pol; 1987; 30(7):409-18. PubMed ID: 3316787
    [No Abstract]   [Full Text] [Related]  

  • 8. [Long-term therapy of hypertrophic obstructive and non-obstructive cardiomyopathy with nifedipine in comparison to propranolol].
    Cserhalmi L; Assmann I; Glavanov M; Rev J; Kelecseńeyi Z
    Z Gesamte Inn Med; 1984 Jul; 39(14):330-5. PubMed ID: 6435321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertrophic occlusive cardiomyopathy.
    Kaltenbach M; Hopf R
    Clin Invest Med; 1980; 3(1-2):179-84. PubMed ID: 7008998
    [No Abstract]   [Full Text] [Related]  

  • 10. Hemodynamic long-term results after medical and surgical therapy of hypertrophic cardiomyopathies.
    Lösse B; Loogen F; Schulte HD
    Z Kardiol; 1987; 76 Suppl 3():119-30. PubMed ID: 3433864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ventricular and myocardial function of the pressure-overloaded left ventricle during exercise (author's transl)].
    Jehle J; Lauber A; Schmiel FK; Spiller P
    Herz; 1981 Oct; 6(5):300-9. PubMed ID: 7197660
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of hypertrophic cardiomyopathy with nifedipine and propranolol in combination].
    Hopf R; Thomas J; Klepzig H; Kaltenbach M
    Z Kardiol; 1987 Aug; 76(8):469-78. PubMed ID: 3673167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy.
    Rosing DR; Kent KM; Maron BJ; Condit J; Epstein SE
    Clin Invest Med; 1980; 3(1-2):195-203. PubMed ID: 7009000
    [No Abstract]   [Full Text] [Related]  

  • 14. [Importance of current ultrasonic study methods for the diagnosis, follow-up of treatment effectiveness and prognosis of patients with hypertrophic obstructive cardiomyopathy].
    Pal L; Fedorova IF; Schäfer R; Sergakova LM; Naumov VG
    Ter Arkh; 1987; 59(10):90-4. PubMed ID: 3433228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nifedipine in the treatment of hypertrophic non-obstructive cardiomyopathy].
    Senn M; Hess OM; Krayenbühl HP
    Schweiz Med Wochenschr; 1982 Sep; 112(38):1312-7. PubMed ID: 6215710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Systolic times of the left ventricle in hypertrophic obstructive cardiomyopathy: effects of beta-adrenergic stimulation and blocking].
    Giovannini E; Ferrari O; Pace F; Milazzotto F
    Boll Soc Ital Cardiol; 1975; 20(11):1595-600. PubMed ID: 1241953
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative study of the effects of verapamil and propranolol therapy in 16 cases of obstructive hypertrophic myocardiopathy].
    Cosnay P; Fauchier JP; Lang M; Casset D; Raynaud P; Lavigne G; Itti R
    Arch Mal Coeur Vaiss; 1987 Mar; 80(3):346-55. PubMed ID: 3113357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of hemodynamic and histological data in hypertrophic subvalvular aortic stenosis. Therapeutic discussion (author's transl)].
    Drobinski G; Komajda M; Tereau Y; Kin G; Evans JI; Eugene M; Laurenceau JL; Grosgogeat Y
    Ann Cardiol Angeiol (Paris); 1980; 29(5):347-52. PubMed ID: 7191687
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug treatment of hypertrophic cardiomyopathy].
    Hirzel HO
    Herz; 1985 Apr; 10(2):84-90. PubMed ID: 4039293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Foundations and indications of the surgical treatment of obstructive cardiomyopathy of the left ventricle. Clinical data, and results in a series of 40 cases subjected to myotomy (author's transl)].
    Michaud P; Dalloz C; Age C; Chassignolle J; Champsaur G; Haggag I
    Ann Radiol (Paris); 1977; 20(3-4):429-42. PubMed ID: 560167
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.